Title : A Dose-Ranging Study of the DPP-IV Inhibitor PF-734200 Added to Metformin in Subjects With Type 2 Diabetes*.

Pub. Date : 2011 Jul

PMID : 21472661






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The purpose of this phase 2, multicentre, randomized, double-blind, placebo-controlled, 12-week dose-ranging study was to assess the efficacy, safety, and tolerability of the dipeptidyl peptidase-IV (DPP-IV) inhibitor PF-734200 in adult subjects with type 2 diabetes who were on a stable dose of metformin. Metformin dipeptidyl peptidase 4 Homo sapiens